ESSA Pharma Ownership | Who Owns ESSA Pharma?
ESSA Pharma Ownership Summary
ESSA Pharma is owned by 79.12% institutional investors, 2.26% insiders, and 18.61% retail investors. Bvf inc/il is the largest institutional shareholder, holding 19.78% of EPIX shares. BB Biotech AG Ord is the top mutual fund, with 17.76% of its assets in ESSA Pharma shares.
EPIX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ESSA Pharma | 79.12% | 2.26% | 18.61% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bvf inc/il | 8.75M | 19.78% | $46.02M |
| Bellevue group | 7.89M | 17.83% | $41.50M |
| Soleus capital management | 4.21M | 9.52% | $22.15M |
| Morgan stanley | 4.18M | 9.44% | $21.98M |
| Pfm health sciences, lp | 2.97M | 6.70% | $15.60M |
| Rtw investments, lp | 2.30M | 5.20% | $12.09M |
| Adage capital partners gp | 1.47M | 3.33% | $7.75M |
| Rhenman & partners asset management ab | 806.05K | 1.82% | $4.24M |
| Rock springs capital management lp | 677.00K | 1.53% | $3.56M |
| Schonfeld strategic advisors | 315.74K | 0.71% | $1.66M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Soleus capital management | 4.21M | 1.95% | $22.15M |
| Bvf inc/il | 8.75M | 1.29% | $46.02M |
| Pfm health sciences, lp | 2.97M | 0.77% | $15.60M |
| Bellevue group | 7.89M | 0.67% | $41.50M |
| Rhenman & partners asset management ab | 806.05K | 0.41% | $4.24M |
| Rtw investments, lp | 2.30M | 0.19% | $12.09M |
| Parkman healthcare partners | 252.07K | 0.18% | $1.33M |
| Rock springs capital management lp | 677.00K | 0.11% | $3.56M |
| Adage capital partners gp | 1.47M | 0.01% | $7.75M |
| Schonfeld strategic advisors | 315.74K | 0.01% | $1.66M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Soleus capital management | 4.21M | 1.95% | 620.98K |
| Kennedy capital management | 34.47K | 0.00% | 34.47K |
| Two sigma investments, lp | 10.31K | 0.00% | 10.31K |
| Royal bank of canada | 36.31K | - | 5.54K |
| Federation des caisses desjardins du quebec | 2.05K | 0.00% | 2.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | - | - | -1.01M |
| Adage capital partners gp | 1.47M | 0.01% | -106.21K |
| Rhenman & partners asset management ab | 806.05K | 0.41% | -105.77K |
| Schonfeld strategic advisors | 315.74K | 0.01% | -52.76K |
| Tucker asset management | - | - | -16.10K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Kennedy capital management | 34.47K | 0.00% | 34.47K | $181.29K |
| Two sigma investments, lp | 10.31K | 0.00% | 10.31K | $54.25K |
Sold Out
| Holder | Change |
|---|---|
| Toronto dominion bank | -48.00 |
| Simplex trading | -4.33K |
| Entrypoint capital | -4.42K |
| Millennium management | -14.05K |
| Susquehanna group, llp | -15.70K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 35 | 2.94% | 35,103,052 | -0.30% | 79 | 1.25% | 15 | 87.50% | 8 | -27.27% |
| Jun 30, 2024 | 34 | -8.11% | 35,208,390 | 0.49% | 79 | 1.26% | 8 | -33.33% | 11 | 10.00% |
| Mar 31, 2024 | 37 | 5.71% | 35,037,057 | 0.76% | 79 | 1.28% | 12 | -20.00% | 10 | 66.67% |
| Dec 31, 2023 | 35 | -10.26% | 34,772,388 | 3.89% | 78 | 1.37% | 15 | 25.00% | 6 | -40.00% |
| Sep 30, 2023 | 39 | -9.30% | 33,469,182 | 0.60% | 75 | 1.33% | 12 | 20.00% | 10 | -16.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 7.88M | 17.76% | - |
| Rhenman Healthcare Equity L/S RC2 SEK | 804.65K | 1.81% | -1.41K |
| MEDICAL BioHealth EUR Acc | 214.80K | 0.48% | - |
| RIM Global Bioscience EUR | 54.50K | 0.12% | 8.00K |
| Avantis US Small Cap Equity ETF | 46.51K | 0.10% | - |
| Kennedy Micro Cap Opportunities | 40.85K | 0.09% | 7.46K |
| Fidelity Nasdaq Composite Index | 26.86K | 0.06% | - |
| Bellevue (Lux) Bellevue Glbl Mac I EUR | 19.00K | 0.04% | - |
| NT Quality SCC US Fund - L | 2.09K | 0.00% | -354.00 |
| NT Quality Small Cap Core | 2.09K | 0.00% | -354.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 01, 2024 | BIOTECH GROWTH N V | - | Sell | $2.84M |
| Nov 01, 2024 | BIOTECH GROWTH N V | - | Sell | $3.06M |
| Nov 01, 2024 | BIOTECH GROWTH N V | - | Sell | $3.05M |
| Nov 01, 2024 | BIOTECH GROWTH N V | - | Sell | $3.06M |
| Sep 09, 2024 | Virsik Peter | Chief Operating Officer | Sell | $4.16K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | 2 |
| 2024 Q2 | - | 2 |
| 2024 Q1 | - | 6 |
| 2023 Q4 | 4 | - |
| 2023 Q2 | - | - |
EPIX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools